{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T11:13:00Z","timestamp":1721646780452},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2020,1,22]],"date-time":"2020-01-22T00:00:00Z","timestamp":1579651200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,22]],"date-time":"2020-01-22T00:00:00Z","timestamp":1579651200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lasers Med Sci"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s10103-020-02960-0","type":"journal-article","created":{"date-parts":[[2020,1,22]],"date-time":"2020-01-22T06:03:23Z","timestamp":1579673003000},"page":"1695-1701","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The value of transurethral thulium laser en bloc resection combined with a single immediate postoperative intravesical instillation of pirarubicin in primary non-muscle-invasive bladder cancer"],"prefix":"10.1007","volume":"35","author":[{"given":"Sheng","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaoying","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingming","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianping","family":"Che","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,1,22]]},"reference":[{"key":"2960_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394\u2013424","journal-title":"CA Cancer J Clin"},{"key":"2960_CR2","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.eururo.2012.07.033","volume":"63","author":"M Burger","year":"2013","unstructured":"Burger M, Catto JW, Dalbagni G, Grossman HB, Herr H, Karakiewicz P et al (2013) Epidemiology and risk factors of urothelial bladder cancer. Eur Urol 63:234\u2013241","journal-title":"Eur Urol"},{"key":"2960_CR3","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.eururo.2005.12.031","volume":"49","author":"RJ Sylvester","year":"2006","unstructured":"Sylvester RJ, van der Meijden AP, Oosterlinck W, Witjes JA, Bouffioux C, Denis L et al (2006) Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol 49:466\u2013465 discussion 475-477","journal-title":"Eur Urol"},{"key":"2960_CR4","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.eururo.2016.05.041","volume":"71","author":"M Babjuk","year":"2017","unstructured":"Babjuk M, B\u00f6hle A, Burger M, Capoun O, Cohen D, Comp\u00e9rat EM et al (2017) EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2016. Eur Urol 71:447\u2013461","journal-title":"Eur Urol"},{"key":"2960_CR5","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.eururo.2009.05.047","volume":"57","author":"P Mariappan","year":"2010","unstructured":"Mariappan P, Zachou A, Grigor KM, Edinburgh Uro-Oncology Group (2010) Detrusor muscle in the first, apparently complete transurethral resection of bladder tumour specimen is a surrogate marker of resection quality, predicts risk of early recurrence, and is dependent on operator experience. Eur Urol 57:843\u2013849","journal-title":"Eur Urol"},{"key":"2960_CR6","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.eururo.2014.06.040","volume":"67","author":"P Gontero","year":"2015","unstructured":"Gontero P, Sylvester R, Pisano F, Joniau S, Vander Eeckt K, Serretta V et al (2015) Prognostic factors and risk groups in T1G3 non-muscle-invasive bladder cancer patients initially treated with Bacillus Calmette-Gu\u00e9rin: results of a retrospective multicenter study of 2451 patients. Eur Urol 67:74\u201382","journal-title":"Eur Urol"},{"key":"2960_CR7","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s00345-011-0680-5","volume":"29","author":"MW Kramer","year":"2011","unstructured":"Kramer MW, Bach T, Wolters M, Imkamp F, Gross AJ, Kuczyk MA et al (2011) Current evidence for transurethral laser therapy of non-muscle invasive bladder cancer. World J Urol 29:433\u2013442","journal-title":"World J Urol"},{"key":"2960_CR8","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.euf.2016.12.004","volume":"3","author":"MW Kramer","year":"2017","unstructured":"Kramer MW, Altieri V, Hurle R, Lusuardi L, Merseburger AS, Rassweiler J et al (2017) Current evidence of transurethral en-bloc resection of nonmuscle invasive bladder Cancer. Eur Urol Focus 3:567\u2013576","journal-title":"Eur Urol Focus"},{"key":"2960_CR9","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.eururo.2007.08.015","volume":"53","author":"JA Witjes","year":"2008","unstructured":"Witjes JA, Hendricksen K (2008) Intravesical pharmacotherapy for non-muscle-invasive bladder cancer: a critical analysis of currently available drugs, treatment schedules, and long-term results. Eur Urol 53:45\u201352","journal-title":"Eur Urol"},{"key":"2960_CR10","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1111\/j.1442-2042.2008.02235.x","volume":"16","author":"E Kikuchi","year":"2009","unstructured":"Kikuchi E, Fujimoto H, Mizutani Y, Okajima E, Koga H, Hinotsu S et al (2009) Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association. Int J Urol 16:279\u2013286","journal-title":"Int J Urol"},{"key":"2960_CR11","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1007\/s00345-015-1568-6","volume":"33","author":"MW Kramer","year":"2015","unstructured":"Kramer MW, Rassweiler JJ, Klein J, Martov A, Baykov N, Lusuardi L et al (2015) En bloc resection of urothelium carcinoma of the bladder (EBRUC): a European multicenter study to compare safety, efficacy, and outcome of laser and electrical en bloc transurethral resection of bladder tumor. World J Urol 33:1937\u20131943","journal-title":"World J Urol"},{"key":"2960_CR12","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.eururo.2008.01.015","volume":"53","author":"RJ Sylvester","year":"2008","unstructured":"Sylvester RJ, Oosterlinck W, Witjes JA (2008) The schedule and duration of intravesical chemotherapy in patients with non-muscle-invasive bladder cancer: a systematic review of the published results of randomized clinical trials. Eur Urol 53:709\u2013719","journal-title":"Eur Urol"},{"key":"2960_CR13","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.eururo.2015.05.050","volume":"69","author":"RJ Sylvester","year":"2016","unstructured":"Sylvester RJ, Oosterlinck W, Holmang S, Sydes MR, Birtle A, Gudjonsson S et al (2016) Systematic review and individual patient data meta-analysis of randomized trials comparing a single immediate instillation of chemotherapy after transurethral resection with transurethral resection alone in patients with stage pTa-pT1 Urothelial carcinoma of the bladder: which patients benefit from the instillation. Eur Urol 69:231\u2013244","journal-title":"Eur Urol"},{"key":"2960_CR14","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1016\/S0022-5347(05)67707-5","volume":"163","author":"DL Lamm","year":"2000","unstructured":"Lamm DL, Blumenstein BA, Crissman JD, Montie JE, Gottesman JE, Lowe BA et al (2000) Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized southwest oncology group study. J Urol 163:1124\u20131129","journal-title":"J Urol"},{"key":"2960_CR15","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1111\/iju.13167","volume":"23","author":"Y Nakai","year":"2016","unstructured":"Nakai Y, Anai S, Tanaka N, Chihara Y, Haramoto M, Otani T et al (2016) Insignificant role of bacillus Calmette-Gu\u00e9rin maintenance therapy after complete transurethral resection of bladder tumor for intermediate- and high-risk non-muscle-invasive bladder cancer: results from a randomized trial. Int J Urol 23:854\u2013860","journal-title":"Int J Urol"},{"key":"2960_CR16","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/j.eururo.2007.02.063","volume":"52","author":"MG Friedrich","year":"2007","unstructured":"Friedrich MG, Pichlmeier U, Schwaibold H, Conrad S, Huland H (2007) Long-term intravesical adjuvant chemotherapy further reduces recurrence rate compared with short-term intravesical chemotherapy and short-term therapy with Bacillus Calmette-Gu\u00e9rin (BCG) in patients with non-muscle-invasive bladder carcinoma. Eur Urol 52:1123\u20131129","journal-title":"Eur Urol"},{"key":"2960_CR17","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1111\/j.1464-410X.2009.09153.x","volume":"106","author":"V Serretta","year":"2010","unstructured":"Serretta V, Morgia G, Altieri V, Di Lallo A, Ruggiero G, Salzano L et al (2010) A 1-year maintenance after early adjuvant intravesical chemotherapy has a limited efficacy in preventing recurrence of intermediate risk non-muscle-invasive bladder cancer. BJU Int 106:212\u2013217","journal-title":"BJU Int"},{"key":"2960_CR18","doi-asserted-by":"publisher","first-page":"e12740","DOI":"10.1097\/MD.0000000000012740","volume":"97","author":"Y Naya","year":"2018","unstructured":"Naya Y, Mikami K, Takaha N, Inoue Y, Fujihara A, Kanazawa M et al (2018) Randomized study of intravesical pirarubicin chemotherapy with low and intermediate-risk nonmuscle-invasive bladder cancer in Japan: comparison of a single immediate postoperative intravesical instillation with short-term adjuvant intravesical instillations after transurethral resection. Medicine (Baltimore) 97:e12740","journal-title":"Medicine (Baltimore)"},{"key":"2960_CR19","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.eururo.2010.03.007","volume":"58","author":"RT Divrik","year":"2010","unstructured":"Divrik RT, Sahin AF, Yildirim U, Altok M, Zorlu F (2010) Impact of routine second transurethral resection on the long-term outcome of patients with newly diagnosed pT1 urothelial carcinoma with respect to recurrence, progression rate, and disease-specific survival: a prospective randomised clinical trial. Eur Urol 58:185\u2013190","journal-title":"Eur Urol"},{"key":"2960_CR20","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1016\/S0022-5347(05)01002-5","volume":"175","author":"RT Divrik","year":"2006","unstructured":"Divrik RT, Yildirim U, Zorlu F, Ozen H (2006) The effect of repeat transurethral resection on recurrence and progression rates in patients with T1 tumors of the bladder who received intravesical mitomycin: a prospective, randomized clinical trial. J Urol 175:1641\u20131644","journal-title":"J Urol"},{"key":"2960_CR21","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.urology.2016.01.004","volume":"90","author":"R Hurle","year":"2016","unstructured":"Hurle R, Lazzeri M, Colombo P, Buffi N, Morenghi E, Peschechera R et al (2016) \"En bloc\" resection of nonmuscle invasive bladder Cancer: a prospective single-center study. Urology 90:126\u2013130","journal-title":"Urology"},{"key":"2960_CR22","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1186\/s12885-015-1859-8","volume":"15","author":"\u00d6 Acar","year":"2015","unstructured":"Acar \u00d6, \u00d6zkurt E, Demir G, Sara\u00e7 H, Alkan C, Esen T et al (2015) Determining the origin of synchronous multifocal bladder cancer by exome sequencing. BMC Cancer 15:871","journal-title":"BMC Cancer"},{"key":"2960_CR23","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s00345-011-0659-2","volume":"29","author":"EC Cauberg","year":"2011","unstructured":"Cauberg EC, Mamoulakis C, de la Rosette JJ, de Reijke TM (2011) Narrow band imaging-assisted transurethral resection for non-muscle invasive bladder cancer significantly reduces residual tumour rate. World J Urol 29:503\u2013509","journal-title":"World J Urol"},{"key":"2960_CR24","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1089\/end.2012.0549","volume":"27","author":"TC Chang","year":"2013","unstructured":"Chang TC, Liu JJ, Hsiao ST, Pan Y, Mach KE, Leppert JT et al (2013) Interobserver agreement of confocal laser endomicroscopy for bladder cancer. J Endourol 27:598\u2013603","journal-title":"J Endourol"}],"container-title":["Lasers in Medical Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10103-020-02960-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10103-020-02960-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10103-020-02960-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,21]],"date-time":"2021-01-21T00:30:18Z","timestamp":1611189018000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10103-020-02960-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,22]]},"references-count":24,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["2960"],"URL":"https:\/\/doi.org\/10.1007\/s10103-020-02960-0","relation":{},"ISSN":["0268-8921","1435-604X"],"issn-type":[{"value":"0268-8921","type":"print"},{"value":"1435-604X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,22]]},"assertion":[{"value":"3 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"We state no conflict of interests and funding sources exit in the preparation and submission of this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The authors claim that none of the materials in the paper have been published or are under consideration for publication elsewhere.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}